Physician profile
Marta T Hampton
NPI 1952403446
$24,448.25
in general payments reported to CMS, 2019-2025
33 companies · $1,736 in 2025
The $1,736 reported for 2025 was more than what 83% of Dermatopathology (Dermatology) providers received nationally (typical 2025 total: $251).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $598 · 2021: $3,436 · 2022: $905 · 2023: $3,523 · 2024: $1,742 · 2025: $1,736.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,308 · Consulting Fee: $1,180 · Education: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,307.54 |
| Consulting Fee | $1,180.00 |
| Education | $513.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13,437.65 | 2019-2025 | |
| Abbvie INC. | $1,853.03 | 2019-2025 | |
| Janssen Biotech, INC. | $1,459.99 | 2019-2025 | Tremfya, Simponi Aria, Stelara |
| Sun Pharmaceutical Industries INC. | $1,434.46 | 2019-2025 | Ilumya |
| Ucb, INC. | $1,425.00 | 2019-2025 | Bimzelx, Cimzia |
| Pfizer INC. | $518.63 | 2019-2025 | |
| Lilly USA, LLC | $463.22 | 2019-2025 | Ebglyss |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $442.51 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $409.75 | 2019-2025 | Libtayo |
| Dermavant Sciences, INC. | $382.07 | 2023-2024 | Vtama |
| Amgen INC. | $378.38 | 2019-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $285.43 | 2022-2025 | Sotyktu |
| Incyte Corporation | $260.22 | 2023-2025 | Opzelura |
| Genzyme Corporation | $232.91 | 2021-2024 | |
| Genentech USA, INC. | $195.98 | 2019-2023 | Xolair |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $169.91 | 2023-2025 | Zoryve |
| Galderma Laboratories, L.P. | $164.07 | 2019-2025 | Aklief |
| Janssen Scientific Affairs, LLC | $154.66 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $148.37 | 2023-2025 | Nuzyra |
| Leo Pharma INC. | $94.13 | 2019-2023 | Adbry |
| Mayne Pharma Commercial LLC | $79.81 | 2019-2025 | |
| Celgene Corporation | $78.07 | 2019 | |
| Almirall LLC | $72.05 | 2019-2022 | |
| Sanofi-Aventis U.S. LLC | $72.00 | 2021 | |
| Prugen, INC. Pharmaceuticals | $58.36 | 2019 | |
| Sandoz INC. | $41.95 | 2024-2025 | Hyrimoz |
| Dermira, INC. | $40.19 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $24.94 | 2019 | |
| Aclaris Therapeutics, INC. | $16.03 | 2019 | |
| Mission Pharmacal Company | $14.89 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $13.32 | 2019 | |
| Promius Pharma LLC | $13.31 | 2019 | |
| Encore Dermatology INC. | $12.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marta Hampton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.